(Q42729744)

5 November 2017

Antitumor activity of LSD1 inhibitors in lung cancer (English)

1 reference

5 November 2017

Helai P Mohammad

1

1 reference

PMC publication ID

4905412

5 November 2017

Ryan G Kruger

series ordinal

2

1 reference

5 November 2017

6 January 2016

1 reference

Molecular & cellular oncology

5 November 2017

1 reference

5 November 2017

3

1 reference

5 November 2017

2

1 reference

5 November 2017

e1117700

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

5 November 2017

start time

6 January 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Origins, genetic landscape, and emerging therapies of small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

Chromatin proteins and modifications as drug targets

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

Medical treatment of small cell lung cancer: state of the art and new development

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

LSD1 inhibition: a therapeutic strategy in cancer?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4905412

10.1080/23723556.2015.1117700

16 August 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference

PMC publication ID

4905412

5 November 2017

PubMed publication ID

27308632

1 reference

PMC publication ID

4905412